Relay Therapeutics Ownership 2024 | Who Owns Relay Therapeutics Now?
Institutional Ownership
11.66%
Insider Ownership
2.14%
Retail Ownership
86.20%
Institutional Holders
70.00
Relay Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 21.01% | 1.68% | 27,904,963 | - | - | 181,940,359 | Jun 30, 2024 |
| VANGUARD GROUP INC | 8.81% | 0.00% | 11,704,866 | -110,803 | -0.94% | 76,315,726 | Jun 30, 2024 |
| BLACKROCK INC. | 7.94% | 0.00% | 10,542,667 | 746,457 | 7.62% | 68,738,188 | Jun 30, 2024 |
| CASDIN CAPITAL, LLC | 6.36% | 4.22% | 8,448,574 | 1,025,000 | 13.81% | 55,084,702 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 4.80% | 0.68% | 6,377,115 | 450,497 | 7.60% | 41,578,790 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.79% | 0.00% | 5,039,015 | -1,840,582 | -26.75% | 32,855,000 | Jun 30, 2024 |
| STATE STREET CORP | 3.20% | 0.00% | 4,248,406 | -1,772,582 | -29.44% | 27,699,607,000 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 2.98% | 0.00% | 3,963,401 | 246,133 | 6.62% | 25,841,376 | Jun 30, 2024 |
| NEXTECH INVEST LTD. | 2.90% | 4.22% | 3,846,409 | - | - | 25,078,587 | Jun 30, 2024 |
| NORGES BANK | 2.50% | 0.00% | 3,319,342 | 3,319,342 | 100.00% | 21,642,110 | Jun 30, 2024 |
| BRAIDWELL LP | 2.26% | 0.61% | 3,006,799 | -737,200 | -19.69% | 19,604,329 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.78% | 0.00% | 2,364,797 | 148,004 | 6.68% | 15,421,916 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 1.37% | 0.62% | 1,819,132 | - | - | 11,860,741 | Jun 30, 2024 |
| FINEPOINT CAPITAL LP | 1.21% | 2.97% | 1,605,346 | 115,176 | 7.73% | 10,466,856 | Jun 30, 2024 |
| ALPHABET INC. | 1.18% | 0.52% | 1,568,753 | - | - | 10,228,270 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.14% | 0.00% | 1,520,340 | -80,474 | -5.03% | 9,911,288 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.12% | 0.00% | 1,484,518 | -278,630 | -15.80% | 9,679,057 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 0.98% | 0.69% | 1,300,000 | 1,300,000 | 100.00% | 8,476,000 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 0.96% | 1.29% | 1,274,459 | 442,442 | 53.18% | 8,309,473 | Jun 30, 2024 |
| MORGAN STANLEY | 0.94% | 0.00% | 1,242,278 | 85,257 | 7.37% | 8,099,656 | Jun 30, 2024 |
Relay Therapeutics's largest institutional shareholder is SB INVESTMENT ADVISERS (UK) LTD, holding 21.01% of the company's total share outstanding, currently valued at $181.94M. The top 10 institutional shareholders own together 64.29% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CASDIN CAPITAL, LLC | 6.36% | 4.22% | 8,448,574 | 1,025,000 | 13.81% | 55,084,702 | Jun 30, 2024 |
| NEXTECH INVEST LTD. | 2.90% | 4.22% | 3,846,409 | - | - | 25,078,587 | Jun 30, 2024 |
| FINEPOINT CAPITAL LP | 1.21% | 2.97% | 1,605,346 | 115,176 | 7.73% | 10,466,856 | Jun 30, 2024 |
| SB INVESTMENT ADVISERS (UK) LTD | 21.01% | 1.68% | 27,904,963 | - | - | 181,940,359 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 0.96% | 1.29% | 1,274,459 | 442,442 | 53.18% | 8,309,473 | Jun 30, 2024 |
| HARBOURVEST PARTNERS LLC | 0.22% | 1.03% | 296,402 | - | - | 1,932,541 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 0.29% | 0.75% | 385,000 | -65,000 | -14.44% | 2,510,200 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 0.98% | 0.69% | 1,300,000 | 1,300,000 | 100.00% | 8,476,000 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 4.80% | 0.68% | 6,377,115 | 450,497 | 7.60% | 41,578,790 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 1.37% | 0.62% | 1,819,132 | - | - | 11,860,741 | Jun 30, 2024 |
| BRAIDWELL LP | 2.26% | 0.61% | 3,006,799 | -737,200 | -19.69% | 19,604,329 | Jun 30, 2024 |
| ALPHABET INC. | 1.18% | 0.52% | 1,568,753 | - | - | 10,228,270 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.56% | 0.46% | 750,000 | 25,000 | 3.45% | 4,890,000 | Jun 30, 2024 |
| FERNWOOD INVESTMENT MANAGEMENT, LLC | 0.14% | 0.38% | 185,763 | - | - | 1,211,175 | Jun 30, 2024 |
| BRANDYWINE MANAGERS, LLC | 0.02% | 0.22% | 31,807 | - | - | 207,382 | Jun 30, 2024 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 0.17% | 0.14% | 230,000 | - | - | 1,499,600 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.17% | 0.14% | 226,632 | 73,641 | 48.13% | 1,477,641 | Jun 30, 2024 |
| TRUEMARK INVESTMENTS, LLC | 0.04% | 0.12% | 54,445 | - | - | 354,981 | Jun 30, 2024 |
| INTELLECTUS PARTNERS, LLC | 0.05% | 0.12% | 67,675 | -1,585 | -2.29% | 441,241 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.36% | 0.10% | 476,888 | 174,953 | 57.94% | 3,109,000 | Jun 30, 2024 |
The largest Relay Therapeutics shareholder by % of total assets is CASDIN CAPITAL, LLC. The company owns 8.45M shares of Relay Therapeutics (RLAY), representing 4.22% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NORGES BANK | 2.50% | 0.00% | 3,319,342 | 3,319,342 | 100.00% | 21,642,110 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 0.98% | 0.69% | 1,300,000 | 1,300,000 | 100.00% | 8,476,000 | Jun 30, 2024 |
| CASDIN CAPITAL, LLC | 6.36% | 4.22% | 8,448,574 | 1,025,000 | 13.81% | 55,084,702 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.90% | 0.03% | 1,191,183 | 984,427 | 476.13% | 7,766,513 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.87% | 0.00% | 1,149,177 | 921,271 | 404.23% | 7,492,634 | Jun 30, 2024 |
| BLACKROCK INC. | 7.94% | 0.00% | 10,542,667 | 746,457 | 7.62% | 68,738,188 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 4.80% | 0.68% | 6,377,115 | 450,497 | 7.60% | 41,578,790 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 0.96% | 1.29% | 1,274,459 | 442,442 | 53.18% | 8,309,473 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.21% | 0.00% | 276,702 | 276,702 | 100.00% | 1,804,096 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 2.98% | 0.00% | 3,963,401 | 246,133 | 6.62% | 25,841,376 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0.46% | 0.04% | 616,220 | 218,302 | 54.86% | 4,017,754 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 0.53% | 0.03% | 703,429 | 195,000 | 38.35% | 4,586,143 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.34% | 0.00% | 446,808 | 184,925 | 70.61% | 2,913,189 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.14% | 0.02% | 184,621 | 184,621 | 100.00% | 1,203,729 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.36% | 0.10% | 476,888 | 174,953 | 57.94% | 3,109,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.78% | 0.00% | 2,364,797 | 148,004 | 6.68% | 15,421,916 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.68% | 0.01% | 909,037 | 145,837 | 19.11% | 5,926,921 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.11% | 0.00% | 144,986 | 144,986 | 100.00% | 945,309 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.55% | 0.01% | 730,022 | 142,332 | 24.22% | 4,759,743 | Jun 30, 2024 |
| THRIVENT FINANCIAL FOR LUTHERANS | 0.09% | 0.00% | 120,011 | 120,011 | 100.00% | 782,000 | Jun 30, 2024 |
As of Jun 30 2024, Relay Therapeutics's largest institutional buyer is NORGES BANK. The company purchased 3.32M stocks of RLAY, valued at $21.64M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARROWMARK COLORADO HOLDINGS LLC | 0.41% | 0.04% | 541,124 | -3,464,046 | -86.49% | 3,528,128 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.79% | 0.00% | 5,039,015 | -1,840,582 | -26.75% | 32,855,000 | Jun 30, 2024 |
| STATE STREET CORP | 3.20% | 0.00% | 4,248,406 | -1,772,582 | -29.44% | 27,699,607,000 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -1,675,403 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | 0.05% | - | 70,476 | -1,015,613 | -93.51% | 459,503 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -952,019 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.05% | 0.00% | 65,989 | -933,650 | -93.40% | 430,248 | Jun 30, 2024 |
| BRAIDWELL LP | 2.26% | 0.61% | 3,006,799 | -737,200 | -19.69% | 19,604,329 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.16% | 0.00% | 209,649 | -347,647 | -62.38% | 1,366,912 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.12% | 0.00% | 1,484,518 | -278,630 | -15.80% | 9,679,057 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.15% | 0.00% | 193,932 | -270,128 | -58.21% | 1,264,437 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.17% | 0.00% | 219,725 | -230,447 | -51.19% | 1,432,607 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.01% | 0.00% | 19,427 | -160,545 | -89.21% | 126,663 | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | 0.16% | 0.00% | 206,056 | -152,600 | -42.55% | 1,343,485 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | - | - | - | -118,644 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | 8.81% | 0.00% | 11,704,866 | -110,803 | -0.94% | 76,315,726 | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -101,563 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -100,039 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | 0.14% | 0.00% | 189,320 | -98,606 | -34.25% | 1,234,367 | Jun 30, 2024 |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | - | - | - | -94,341 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Relay Therapeutics's biggest institutional seller is ARROWMARK COLORADO HOLDINGS LLC. The company sold -3.46M shares of RLAY, valued at $3.53M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NORGES BANK | 2.50% | 0.00% | 3,319,342 | 3,319,342 | 100.00% | 21,642,110 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 0.98% | 0.69% | 1,300,000 | 1,300,000 | 100.00% | 8,476,000 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.21% | 0.00% | 276,702 | 276,702 | 100.00% | 1,804,096 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.11% | 0.00% | 144,986 | 144,986 | 100.00% | 945,309 | Jun 30, 2024 |
| THRIVENT FINANCIAL FOR LUTHERANS | 0.09% | 0.00% | 120,011 | 120,011 | 100.00% | 782,000 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.08% | 0.00% | 105,518 | 105,518 | 100.00% | 687,977 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 56,111 | 56,111 | 100.00% | 364,237 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 53,514 | 53,514 | 100.00% | 348,911 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0.04% | 0.01% | 46,702 | 46,702 | 100.00% | 304,497 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.03% | 0.00% | 36,382 | 36,382 | 100.00% | 237,211 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.02% | 0.00% | 26,926 | 26,926 | 100.00% | 175,558 | Jun 30, 2024 |
| ENTROPY TECHNOLOGIES, LP | 0.02% | 0.02% | 22,809 | 22,809 | 100.00% | 148,715 | Jun 30, 2024 |
| VONTOBEL HOLDING LTD. | 0.01% | 0.00% | 14,432 | 14,432 | 100.00% | 94,097 | Jun 30, 2024 |
| EVERSOURCE WEALTH ADVISORS, LLC | 0.00% | 0.00% | 5,750 | 5,750 | 100.00% | 47,265 | Jun 30, 2024 |
| QUADRANT CAPITAL GROUP LLC | 0.00% | 0.00% | 1,096 | 1,096 | 100.00% | 7,146 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 1,038 | 1,038 | 100.00% | 6,768 | Jun 30, 2024 |
| SIGNATUREFD, LLC | 0.00% | 0.00% | 624 | 624 | 100.00% | 4,068 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 306 | 306 | 100.00% | 1,927 | Jun 30, 2024 |
| RONALD BLUE TRUST, INC. | - | - | 52 | 52 | 100.00% | 432 | Jun 30, 2024 |
| TFC FINANCIAL MANAGEMENT, INC. | - | - | 1 | 1 | 100.00% | 7 | Jun 30, 2024 |
Relay Therapeutics's largest new institutional shareholder by number of shares is NORGES BANK, purchased 3.32M shares, valued at $21.64M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -1,675,403 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -952,019 | -100.00% | - | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | - | - | - | -118,644 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -101,563 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -100,039 | -100.00% | - | Jun 30, 2024 |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | - | - | - | -94,341 | -100.00% | - | Jun 30, 2024 |
| QUEST PARTNERS LLC | - | - | - | -81,295 | -100.00% | - | Jun 30, 2024 |
| M&T BANK CORP | - | - | - | -54,250 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -46,686 | -100.00% | - | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | - | - | - | -44,632 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -43,382 | -100.00% | - | Jun 30, 2024 |
| HANDELSBANKEN FONDER AB | - | - | - | -39,200 | -100.00% | - | Jun 30, 2024 |
| AXQ CAPITAL, LP | - | - | - | -21,000 | -100.00% | - | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | - | - | - | -16,018 | -100.00% | - | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | - | - | - | -12,675 | -100.00% | - | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | - | - | - | -11,571 | -100.00% | - | Jun 30, 2024 |
| SEI INVESTMENTS CO | - | - | - | -10,692 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -10,461 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -10,316 | -100.00% | - | Jun 30, 2024 |
| AMUNDI | - | - | - | -7,775 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -5,222 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -1,229 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -231 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -229 | -100.00% | - | Jun 30, 2024 |
| PRIVATE WEALTH MANAGEMENT GROUP, LLC | - | - | - | -182 | -100.00% | - | Jun 30, 2024 |
| CAPITAL ADVISORS, LTD. LLC | - | - | - | -92 | -100.00% | - | Jun 30, 2024 |
| WESTEND CAPITAL MANAGEMENT, LLC | - | - | - | -77 | -100.00% | - | Jun 30, 2024 |
| FIRST COMMAND ADVISORY SERVICES, INC. | - | - | - | -25 | -100.00% | - | Jun 30, 2024 |
| FARTHER FINANCE ADVISORS, LLC | - | - | - | -25 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -18 | -100.00% | - | Jun 30, 2024 |
Relay Therapeutics's largest sold out institutional shareholder by shares sold is JACOBS LEVY EQUITY MANAGEMENT, INC, sold -1.68M shares, valued at -, as of undefined.
Relay Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| T. Rowe Price Health Sciences Fund, Inc. | 0.58% | 1,949,139 | -624,191 | -24.26% | Mar 31, 2024 |
| Tema ETF Trust | 0.50% | 22,445 | 335 | 1.52% | Feb 29, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.46% | 2,308,191 | -792,951 | -25.57% | Mar 31, 2024 |
| MERIDIAN FUND INC | 0.37% | 859,551 | -19,352 | -2.20% | Mar 28, 2024 |
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 0.20% | 186,666 | - | - | Jan 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.19% | 599,600 | -52,468 | -8.05% | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.15% | 77,145 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.12% | 451,831 | - | - | Mar 31, 2024 |
| ALGER FUNDS | 0.11% | 109,445 | - | - | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.10% | 865,767 | - | - | Jan 31, 2024 |
| Humankind Benefit Corp | 0.09% | 2,055 | 388 | 23.28% | Dec 31, 2023 |
| VANGUARD EXPLORER FUND | 0.09% | 1,121,009 | - | - | Jan 31, 2024 |
| EntrepreneurShares Series Trust | 0.09% | 24,117 | - | - | Dec 31, 2023 |
| T. Rowe Price Equity Series, Inc. | 0.06% | 98,419 | -22,829 | -18.83% | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.06% | 11,172 | - | - | Mar 28, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.06% | 440,113 | - | - | Mar 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.05% | 111,589 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.04% | 118,000 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.04% | 10,877 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.04% | 91,422 | - | - | Jan 31, 2024 |
| Federated Hermes Equity Funds | 0.03% | 600,000 | - | - | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.03% | 117,294 | 104,676 | 829.58% | Jan 31, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.03% | 299,647 | - | - | Jan 31, 2024 |
| ROYCE MICRO-CAP TRUST, INC. | 0.03% | 14,222 | -17,803 | -55.59% | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.03% | 161,294 | -4,295 | -2.59% | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.03% | 10,703,791 | -284,075 | -2.59% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 13,941 | 119 | 0.86% | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.02% | 237,980 | - | - | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.02% | 213,100 | - | - | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.02% | 1,773,894 | - | - | Jan 31, 2024 |
| AB CAP FUND, INC. | 0.02% | 628,870 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.02% | 57,456 | 930 | 1.65% | Feb 29, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.02% | 159,877 | - | - | Mar 28, 2024 |
| VANGUARD SPECIALIZED FUNDS | 0.02% | 909,447 | - | - | Jan 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.02% | 441,556 | -260,573 | -37.11% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.01% | 117,900 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.01% | 33,915 | - | - | Mar 31, 2024 |
| Listed Funds Trust | 0.01% | 54,445 | 6,487 | 13.53% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 416,697 | 146,956 | 54.48% | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,088 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 532,266 | - | - | Feb 29, 2024 |
| Harbor ETF Trust | 0.01% | 38,263 | -3,156 | -7.62% | Jan 31, 2024 |
| Bernstein Fund Inc | 0.01% | 66,635 | - | - | Mar 31, 2024 |
| UBS FUNDS | 0.01% | 37,186 | - | - | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.01% | 31,818 | 29,362 | 1195.52% | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.01% | 61,206 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 8,239 | -33 | -0.40% | Jan 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.01% | 297,327 | 27,567 | 10.22% | Mar 31, 2024 |
| North Square Investments Trust | 0.00% | 44,660 | 44,660 | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 891,713 | 41,478 | 4.88% | Feb 29, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 210,000 | - | - | Feb 29, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 239,665 | - | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 8,970 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 37,558 | 536 | 1.45% | Mar 31, 2024 |
| AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.00% | 13,658 | - | - | Mar 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 67,050 | 67,050 | - | Mar 31, 2024 |
| NEW COVENANT FUNDS | 0.00% | 11,508 | 11,508 | - | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 55,000 | - | - | Mar 31, 2024 |
| FIDELITY CONTRAFUND | 0.00% | 167,800 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 72,269 | -5,668 | -7.27% | Mar 31, 2024 |
| JPMORGAN INSURANCE TRUST | 0.00% | 29,320 | -1,230 | -4.03% | Mar 31, 2023 |
| JPMORGAN TRUST II | 0.00% | 2,139,270 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 287,470 | 52,406 | 22.29% | Mar 31, 2024 |
| ProFunds | 0.00% | 24,295 | 5,123 | 26.72% | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 314,492 | 17,841 | 6.01% | Jan 31, 2024 |
| MML SERIES INVESTMENT FUND | 0.00% | 18,788 | - | - | Dec 31, 2023 |
| FIDELITY COVINGTON TRUST | 0.00% | 30,544 | 10,707 | 53.97% | Mar 31, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 14,600 | 14,600 | - | Mar 28, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 20,172 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 32,074 | 739 | 2.36% | Mar 31, 2024 |
| ETF Managers Trust | 0.00% | 10,533 | - | - | Dec 31, 2023 |
| BAILLIE GIFFORD FUNDS | 0.00% | 13,311 | 607 | 4.78% | Mar 28, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 102,653 | -26,219 | -20.34% | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 14,959 | -1,231 | -7.60% | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 537,367 | 207,053 | 62.68% | Jan 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 289,245 | 5,155 | 1.81% | Feb 29, 2024 |
| VALIC Co I | 0.00% | 333,899 | -36,310 | -9.81% | Feb 29, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 212,500 | - | - | Feb 29, 2024 |
| VALIC Co II | 0.00% | 36,933 | 1,165 | 3.26% | Feb 28, 2021 |
| T. Rowe Price Exchange-Traded Funds, Inc. | 0.00% | 7,152 | - | - | Feb 29, 2024 |
| John Hancock Exchange-Traded Fund Trust | 0.00% | 6,163 | - | - | Jan 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 31,484 | - | - | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 29,880 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 30,051 | -6,672 | -18.17% | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 106,605 | 38,928 | 57.52% | Feb 29, 2024 |
| FINANCIAL INVESTORS TRUST | 0.00% | 73,935 | - | - | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND VI | 0.00% | 5,056 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 4,389 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 37,002 | - | - | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 474,620 | 15,462 | 3.37% | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 17,603 | 2,820 | 19.08% | Feb 29, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 14,951 | - | - | Mar 31, 2024 |
| AMG FUNDS III | 0.00% | 3,598 | - | - | Mar 28, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 4,306 | - | - | Aug 31, 2023 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 38,300 | 7,800 | 25.57% | Mar 31, 2024 |
| Voya INVESTORS TRUST | 0.00% | 32,421 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,583 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 16,976 | -564 | -3.22% | Mar 28, 2024 |
| PRUDENTIAL SERIES FUND | 0.00% | 44,054 | - | - | Mar 28, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 44,969 | - | - | Mar 31, 2024 |
Relay Therapeutics's largest mutual fund holder by % of total assets is "T. Rowe Price Health Sciences Fund, Inc.", owning 1.95M shares, compromising 0.58% of its total assets.
Relay Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 70 | -62.37% |
| 31 Mar, 24 | 186 | 5.68% |
| 31 Dec, 23 | 176 | 2.92% |
| 30 Sep, 23 | 171 | 4.27% |
| 30 Jun, 23 | 164 | 1.23% |
| 31 Mar, 23 | 162 | -2.41% |
| 31 Dec, 22 | 166 | 7.10% |
| 30 Sep, 22 | 155 | 11.51% |
| 30 Jun, 22 | 139 | - |
| 31 Mar, 22 | 139 | 6.11% |
| 31 Dec, 21 | 131 | -8.39% |
| 30 Sep, 21 | 143 | 17.21% |
| 30 Jun, 21 | 122 | -8.96% |
| 31 Mar, 21 | 134 | 19.64% |
| 31 Dec, 20 | 112 | 21.74% |
| 30 Sep, 20 | 92 | - |
As of 30 Jun 24, 70 institutions are holding Relay Therapeutics's shares, representing a decrease of -62.37% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 15,492,387 | -87.97% |
| 31 Mar, 24 | 128,755,897 | 1.37% |
| 31 Dec, 23 | 127,011,599 | -1.51% |
| 30 Sep, 23 | 128,954,757 | 0.32% |
| 30 Jun, 23 | 128,544,444 | -1.84% |
| 31 Mar, 23 | 130,958,182 | 2.24% |
| 31 Dec, 22 | 128,092,096 | 3.80% |
| 30 Sep, 22 | 123,398,227 | 2.34% |
| 30 Jun, 22 | 120,581,972 | 6.63% |
| 31 Mar, 22 | 113,081,602 | 1.91% |
| 31 Dec, 21 | 110,962,477 | 20.94% |
| 30 Sep, 21 | 91,748,243 | 2.96% |
| 30 Jun, 21 | 89,113,089 | 4.16% |
| 31 Mar, 21 | 85,554,630 | -2.38% |
| 31 Dec, 20 | 87,638,161 | -2.91% |
| 30 Sep, 20 | 90,260,290 | - |
Relay Therapeutics (RLAY) has 15.49M shares outstanding as of 30 Jun 24, down -87.97% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 11.66% | 0.12% |
| 31 Mar, 24 | 98.40% | 0.92% |
| 31 Dec, 23 | 103.62% | 0.93% |
| 30 Sep, 23 | 105.50% | 0.95% |
| 30 Jun, 23 | 105.64% | 0.91% |
| 31 Mar, 23 | 107.94% | 0.96% |
| 31 Dec, 22 | 105.89% | 0.86% |
| 30 Sep, 22 | 111.26% | 0.90% |
| 30 Jun, 22 | 110.99% | 1.02% |
| 31 Mar, 22 | 104.42% | 0.77% |
| 31 Dec, 21 | 116.63% | 1.19% |
| 30 Sep, 21 | 98.98% | 1.05% |
| 30 Jun, 21 | 96.93% | 1.08% |
| 31 Mar, 21 | 94.85% | 1.00% |
| 31 Dec, 20 | 97.48% | 0.61% |
| 30 Sep, 20 | 126.68% | - |
As of 30 Jun 24, Relay Therapeutics is held by 11.66% institutional shareholders, representing a 0.12% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 38 | -62.75% |
| 31 Mar, 24 | 102 | 18.60% |
| 31 Dec, 23 | 86 | -4.44% |
| 30 Sep, 23 | 90 | -2.17% |
| 30 Jun, 23 | 92 | 27.78% |
| 31 Mar, 23 | 72 | -30.77% |
| 31 Dec, 22 | 104 | 11.83% |
| 30 Sep, 22 | 93 | 6.90% |
| 30 Jun, 22 | 87 | 31.82% |
| 31 Mar, 22 | 66 | -24.14% |
| 31 Dec, 21 | 87 | 12.99% |
| 30 Sep, 21 | 77 | 6.94% |
| 30 Jun, 21 | 72 | -21.74% |
| 31 Mar, 21 | 92 | 46.03% |
| 31 Dec, 20 | 63 | -31.52% |
| 30 Sep, 20 | 92 | - |
38 institutional shareholders have increased their position in RLAY stock as of 30 Jun 24 compared to 102 in the previous quarter (a -62.75% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 18 | -62.50% |
| 31 Mar, 24 | 48 | -17.24% |
| 31 Dec, 23 | 58 | 31.82% |
| 30 Sep, 23 | 44 | 12.82% |
| 30 Jun, 23 | 39 | -25.00% |
| 31 Mar, 23 | 52 | 57.58% |
| 31 Dec, 22 | 33 | 13.79% |
| 30 Sep, 22 | 29 | 45.00% |
| 30 Jun, 22 | 20 | -47.37% |
| 31 Mar, 22 | 38 | 90.00% |
| 31 Dec, 21 | 20 | -35.48% |
| 30 Sep, 21 | 31 | 47.62% |
| 30 Jun, 21 | 21 | -16.00% |
| 31 Mar, 21 | 25 | 31.58% |
| 31 Dec, 20 | 19 | - |
| 30 Sep, 20 | - | - |
18 institutional shareholders have reduced their position in RLAY stock as of 30 Jun 24 compared to 48 in the previous quarter (a -62.50% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 70 | -62.37% | 15,492,387 | -87.97% | 11.66% | 0.12% | 38 | -62.75% | 18 | -62.50% |
| 31 Mar, 24 | 186 | 5.68% | 128,755,897 | 1.37% | 98.40% | 0.92% | 102 | 18.60% | 48 | -17.24% |
| 31 Dec, 23 | 176 | 2.92% | 127,011,599 | -1.51% | 103.62% | 0.93% | 86 | -4.44% | 58 | 31.82% |
| 30 Sep, 23 | 171 | 4.27% | 128,954,757 | 0.32% | 105.50% | 0.95% | 90 | -2.17% | 44 | 12.82% |
| 30 Jun, 23 | 164 | 1.23% | 128,544,444 | -1.84% | 105.64% | 0.91% | 92 | 27.78% | 39 | -25.00% |
| 31 Mar, 23 | 162 | -2.41% | 130,958,182 | 2.24% | 107.94% | 0.96% | 72 | -30.77% | 52 | 57.58% |
| 31 Dec, 22 | 166 | 7.10% | 128,092,096 | 3.80% | 105.89% | 0.86% | 104 | 11.83% | 33 | 13.79% |
| 30 Sep, 22 | 155 | 11.51% | 123,398,227 | 2.34% | 111.26% | 0.90% | 93 | 6.90% | 29 | 45.00% |
| 30 Jun, 22 | 139 | - | 120,581,972 | 6.63% | 110.99% | 1.02% | 87 | 31.82% | 20 | -47.37% |
| 31 Mar, 22 | 139 | 6.11% | 113,081,602 | 1.91% | 104.42% | 0.77% | 66 | -24.14% | 38 | 90.00% |
| 31 Dec, 21 | 131 | -8.39% | 110,962,477 | 20.94% | 116.63% | 1.19% | 87 | 12.99% | 20 | -35.48% |
| 30 Sep, 21 | 143 | 17.21% | 91,748,243 | 2.96% | 98.98% | 1.05% | 77 | 6.94% | 31 | 47.62% |
| 30 Jun, 21 | 122 | -8.96% | 89,113,089 | 4.16% | 96.93% | 1.08% | 72 | -21.74% | 21 | -16.00% |
| 31 Mar, 21 | 134 | 19.64% | 85,554,630 | -2.38% | 94.85% | 1.00% | 92 | 46.03% | 25 | 31.58% |
| 31 Dec, 20 | 112 | 21.74% | 87,638,161 | -2.91% | 97.48% | 0.61% | 63 | -31.52% | 19 | - |
| 30 Sep, 20 | 92 | - | 90,260,290 | - | 126.68% | - | 92 | - | - | - |
Relay Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Relay Therapeutics's stock was made by Catinazzo Thomas on Jul 31 2024, selling 1,702 shares at $8.85 per share (valued at $15.06K).
Relay Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 2 | 12 | 16.67% |
| Q2 2024 | 10 | 13 | 76.92% |
| Q1 2024 | 5 | 8 | 62.50% |
| Q4 2023 | - | 8 | - |
| Q3 2023 | - | 8 | - |
| Q2 2023 | 11 | 13 | 84.62% |
| Q1 2023 | 13 | 19 | 68.42% |
| Q4 2022 | 6 | 21 | 28.57% |
| Q3 2022 | 4 | 27 | 14.81% |
| Q2 2022 | 15 | 12 | 125.00% |
| Q1 2022 | 11 | 16 | 68.75% |
| Q4 2021 | 4 | 13 | 30.77% |
| Q3 2021 | 2 | 7 | 28.57% |
| Q2 2021 | 10 | 12 | 83.33% |
| Q1 2021 | 14 | 19 | 73.68% |
| Q4 2020 | 4 | - | - |
| Q3 2020 | 15 | 50 | 30.00% |
2 total buy trades, and 12 total sell trades (buy/sell ratio of 0.17%) were made by Relay Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 10 | - |
| Q2 2024 | - | 12 | - |
| Q1 2024 | - | 8 | - |
| Q4 2023 | - | 8 | - |
| Q3 2023 | - | 8 | - |
| Q2 2023 | - | 12 | - |
| Q1 2023 | - | 13 | - |
| Q4 2022 | - | 10 | - |
| Q3 2022 | - | 19 | - |
| Q2 2022 | - | 10 | - |
| Q1 2022 | - | 11 | - |
| Q4 2021 | - | 7 | - |
| Q3 2021 | - | 5 | - |
| Q2 2021 | - | 8 | - |
| Q1 2021 | - | 15 | - |
| Q4 2020 | - | - | - |
| Q3 2020 | 5 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 10 open market sell trades of Relay Therapeutics's stocks.
Relay Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| PLRX | Pliant Therapeutics, Inc. |
| NRIX | Nurix Therapeutics, Inc. |
| ARVN | Arvinas, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| APLS | Apellis Pharmaceuticals, Inc. |
| BPMC | Blueprint Medicines Corporation |
| FHTX | Foghorn Therapeutics Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| IPSC | Century Therapeutics, Inc. |
| BDTX | Black Diamond Therapeutics, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| LIFE | aTyr Pharma, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
RLAY Ownership FAQ
Who Owns Relay Therapeutics?
Relay Therapeutics is owned by institutional shareholders (11.66%), insiders (2.14%), and public (86.20%). The largest institutional shareholder of Relay Therapeutics is SB INVESTMENT ADVISERS (UK) LTD (21.01% of total shares) and the top mutual fund owner is T. Rowe Price Health Sciences Fund, Inc. (0.58% of total shares).
Who are the major institutional shareholders of Relay Therapeutics?
Relay Therapeutics's major institutional shareholders are SB INVESTMENT ADVISERS (UK) LTD, VANGUARD GROUP INC, BLACKROCK INC., CASDIN CAPITAL, LLC, and BELLEVUE GROUP AG. The top five shareholders own together 48.92% of the company's share outstanding.
How many Relay Therapeutics shareholders are there?
As of Jun 2024, there are 70 institutional shareholders of Relay Therapeutics.
What percentage of Relay Therapeutics is owned by SB INVESTMENT ADVISERS (UK) LTD?
SB INVESTMENT ADVISERS (UK) LTD owns 27.9M shares of Relay Therapeutics, representing 21.01% of the company's total shares outstanding, valued at $181.94M (as of Jun 2024).
What percentage of Relay Therapeutics is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 11.7M shares of Relay Therapeutics (RLAY), compromising 8.81% of the company, valued at $76.32M.
What percentage of Relay Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Relay Therapeutics. The company owns 10.54M of the company's shares outstanding (worth $68.74M).